National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7) (No. PB 76 of 2013) (Cth)

PB 76 of 2013

National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7)

National Health Act 1953

I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated              26             November 2013

FELICITY MCNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

Part 1         Preliminary

1. Name of Determination

(1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7).

(2)   This Determination may also be cited as PB 76 of 2013.

1. Commencement

This Determination commences on 1 December 2013.

1. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Albendazole

Insert

Alogliptin

[2]     Schedule 1, after item dealing with Calcium

Insert

Canagliflozin

[3]     Schedule 1, after item dealing with Dabigatran etexilate

Insert

Dabrafenib

[4]     Schedule 1, after item dealing with Dantrolene

Insert

Dapagliflozin

[5]     Schedule 1, after item dealing with Didanosine

Insert

Dimethyl fumarate

[6]     Schedule 1, after item dealing with itraconazole

Insert

Ivabradine

[7]     Schedule 1, after item dealing with Rifampicin

Insert

Rifaximin

[8]     Schedule 1, after item dealing with Terbutaline

Insert

Teriflunomide

[9]     Schedule 1, after item dealing with Zidovudine

Omit

Ziprasidone

[10]   Schedule 2, after item dealing with Vinorelbine

Insert

Ziprasidone